1. A phase I/II trial of vorinostat (SAHA) in combination with rituximab‐CHOP in patients with newly diagnosed advanced stage diffuse large B‐cell lymphoma (DLBCL): SWOG S0806. Issue 4 (25th January 2018) Authors: Persky, Daniel O.; Li, Hongli; Rimsza, Lisa M.; Barr, Paul M.; Popplewell, Leslie L.; Bane, Charles L.; Von Gehr, Ann; LeBlanc, Michael; Fisher, Richard I.; Smith, Sonali M.; Friedberg, Jonathan W. Journal: American journal of hematology Issue: Volume 93:Issue 4(2018:Apr.) Page Start: 486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗